<DOC>
	<DOCNO>NCT02777580</DOCNO>
	<brief_summary>In elderly patient ≥ 70yrs acute ST-elevation myocardial infarction randomise within 3 hour onset symptom efficacy safety strategy early fibrinolytic treatment half-dose tenecteplase additional antiplatelet therapy load dose 300 mg clopidogrel , aspirin couple antithrombin therapy follow catheterisation within 6-24 hour rescue coronary intervention require , compare strategy primary PCI P2Y12 antagonist antithrombin treatment accord local standard .</brief_summary>
	<brief_title>STrategic Reperfusion Elderly Patients Early After Myocardial Infarction</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Tenecteplase</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>1 . Age equal great 70 year 2 . Onset symptoms &lt; 3 hour prior randomisation 3 . 12lead ECG indicative acute STEMI ( STelevation measure J point ; scale : 1 mm per 0.1 mV ) : ≥ 2 mm STelevation across 2 contiguous precordial lead ( V1V6 ) lead I aVL minimum combined total ≥ 4 mm STelevation ≥ 2 mm STelevation 2 contiguous inferior lead ( II , III , aVF ) minimum combined total ≥ 4 mm STelevation 4 . Informed consent receive 1 . 1 . Expected performance PCI &lt; 60 minute diagnosis ( qualify ECG ) inability arrive catheterisation laboratory within 3 hour 2 . Previous CABG 3 . Left bundle branch block ventricular pace 4 . Patients cardiogenic shock Killip Class 4 5 . Patients body weight &lt; 55 kg ( know estimate ) 6 . Uncontrolled hypertension , define sustain blood pressure ≥ 180/110 mm Hg ( systolic BP ≥ 180 mm Hg and/or diastolic BP ≥ 110 mm Hg ) prior randomisation 7 . Known prior stroke TIA 8 . Recent administration i.v . s.c. anticoagulation within 12 hour , include unfractionated heparin , enoxaparin , and/or bivalirudin current use oral anticoagulation ( i.e . warfarin NOACs ) 9 . Active bleed know bleed disorder/diathesis 10 . Known history central nervous system damage ( i.e . neoplasm , aneurysm , intracranial spinal surgery ) recent trauma head cranium ( i.e . &lt; 3 month ) 11 . Major surgery , biopsy parenchymal organ , significant trauma within past 2 month ( include trauma associate current myocardial infarction ) 12 . Clinical diagnosis associate increase risk bleed include know active peptic ulceration and/or neoplasm increase bleed risk 13 . Prolonged cardiopulmonary resuscitation ( &gt; 2 minute ) within past 2 week 14 . Known acute pericarditis and/or subacute bacterial endocarditis 15 . Known acute pancreatitis know severe hepatic dysfunction , include hepatic failure , cirrhosis , portal hypertension ( oesophageal varix ) active hepatitis 16 . Dementia 17 . Known severe renal insufficiency 18 . Previous enrolment study treatment investigational drug device another study protocol past 7 day 19 . Known allergic reaction tenecteplase , clopidogrel , enoxaparin aspirin 20 . Inability follow protocol comply followup requirement reason investigator feel would place patient increase risk investigational therapy initiate .</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Thrombolytic Therapy</keyword>
	<keyword>Primary PCI</keyword>
</DOC>